Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature.

Hu FK, Yuan F, Jiang CY, Lv DW, Mao BB, Zhang Q, Yuan ZQ, Wang Y.

Chin J Cancer. 2011 Nov;30(11):794-804. doi: 10.5732/cjc.011.10013. Review.

2.

A rare case of multiple phosphaturic mesenchymal tumors along a tendon sheath inducing osteomalacia.

Arai R, Onodera T, Terkawi MA, Mitsuhashi T, Kondo E, Iwasaki N.

BMC Musculoskelet Disord. 2017 Feb 13;18(1):79. doi: 10.1186/s12891-017-1446-z.

3.

Phosphaturic mesenchymal tumor, mixed connective tissue variant, of the mandible: report of a case and review of the literature.

Woo VL, Landesberg R, Imel EA, Singer SR, Folpe AL, Econs MJ, Kim T, Harik LR, Jacobs TP.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Dec;108(6):925-32. doi: 10.1016/j.tripleo.2009.07.005. Epub 2009 Oct 14. Review.

4.

Tumor-induced osteomalacia associated with a maxillofacial tumor producing fibroblast growth factor 23: report of a case and review of the literature.

Mori Y, Ogasawara T, Motoi T, Shimizu Y, Chikazu D, Tamura K, Fukumoto S, Takato T.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Mar;109(3):e57-63. doi: 10.1016/j.tripleo.2009.10.052.

PMID:
20219587
5.

[Hypophosphatemic osteomalacia associated phosphaturic mesenchymal tumor of bone: report of a case].

Gong LH, Sun XQ, Xi Y, Ding Y, Huang XY.

Zhonghua Bing Li Xue Za Zhi. 2013 Mar;42(3):201-2. doi: 10.3760/cma.j.issn.0529-5807.2013.03.014. Chinese. No abstract available.

PMID:
23769443
6.

RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and without known tumor induced osteomalacia.

Bahrami A, Weiss SW, Montgomery E, Horvai AE, Jin L, Inwards CY, Folpe AL.

Am J Surg Pathol. 2009 Sep;33(9):1348-54. doi: 10.1097/PAS.0b013e3181aa2311.

PMID:
19609206
7.

Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature.

Jiang Y, Xia WB, Xing XP, Silva BC, Li M, Wang O, Zhang HB, Li F, Jing HL, Zhong DR, Jin J, Gao P, Zhou L, Qi F, Yu W, Bilezikian JP, Meng XW.

J Bone Miner Res. 2012 Sep;27(9):1967-75. doi: 10.1002/jbmr.1642. Review.

8.

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.

Hannan FM, Athanasou NA, Teh J, Gibbons CL, Shine B, Thakker RV.

Eur J Endocrinol. 2008 Feb;158(2):265-71. doi: 10.1530/EJE-07-0485.

9.

The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

Ledford CK, Zelenski NA, Cardona DM, Brigman BE, Eward WC.

Clin Orthop Relat Res. 2013 Nov;471(11):3618-25. doi: 10.1007/s11999-013-3178-1. Epub 2013 Jul 19.

10.

Oncogenic Osteomalacia From a Primary Phosphaturic Mesenchymal Tumor of the Toe: A Case Report.

Kim I, Rajani R.

J Foot Ankle Surg. 2016 Mar-Apr;55(2):294-8. doi: 10.1053/j.jfas.2014.09.012. Epub 2014 Nov 6.

PMID:
25441266
11.

Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.

Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O'Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW.

Am J Surg Pathol. 2004 Jan;28(1):1-30.

PMID:
14707860
12.

Tumor-induced osteomalacia originating from the temporal bone: a case report.

Kobayashi K, Nakao K, Kawai K, Ito K, Hukumoto S, Asakage T, Oota S, Motoi R.

Head Neck. 2011 Jul;33(7):1072-5. doi: 10.1002/hed.21355. Epub 2010 Feb 9.

PMID:
20146335
13.

Osteomalacia-Inducing Tumors of the Brain: A Case Report, Review and a Hypothesis.

Fathalla H, Cusimano M, Di Ieva A, Karamchandani J, Fung R, Kovacs K.

World Neurosurg. 2015 Jul;84(1):189.e1-5. doi: 10.1016/j.wneu.2015.02.030. Epub 2015 Mar 3. Review.

PMID:
25746588
14.

Thoracic phosphaturic mesenchymal tumors causing oncogenic osteomalacia.

Puthenveetil PJ, Hattab EM, Peacock M, Horn EM.

J Clin Neurosci. 2013 Aug;20(8):1057-61. doi: 10.1016/j.jocn.2012.09.035. Epub 2013 Apr 23. Review.

PMID:
23618679
15.

Oncogenic osteomalacia: two case reports with surprisingly different outcomes.

Seijas R, Ares O, Sierra J, Pérez-Dominguez M.

Arch Orthop Trauma Surg. 2009 Apr;129(4):533-9. doi: 10.1007/s00402-008-0808-2. Epub 2009 Jan 6.

PMID:
19125258
16.

A nonphosphaturic mesenchymal tumor mixed connective tissue variant of the sacrum.

Mavrogenis AF, Sakellariou VI, Soultanis K, Mahera H, Korres DS, Papagelopoulos PJ.

Orthopedics. 2010 Nov 2;33(11):851. doi: 10.3928/01477447-20100924-27.

PMID:
21053876
17.

A cytogenetic analysis of 2 cases of phosphaturic mesenchymal tumor of mixed connective tissue type.

Graham RP, Hodge JC, Folpe AL, Oliveira AM, Meyer KJ, Jenkins RB, Sim FH, Sukov WR.

Hum Pathol. 2012 Aug;43(8):1334-8. doi: 10.1016/j.humpath.2011.11.020. Epub 2012 Apr 11.

PMID:
22503486
18.

Phosphaturic mesenchymal tumors. Survey of 8 cases from a single Mexican medical institution.

Angeles-Angeles A, Reza-Albarrán A, Chable-Montero F, Cordova-Ramón JC, Albores-Saavedra J, Martinez-Benitez B.

Ann Diagn Pathol. 2015 Dec;19(6):375-80. doi: 10.1016/j.anndiagpath.2015.08.003. Epub 2015 Aug 28.

PMID:
26386520
19.

Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma.

Slot-Steenks MM, Hamdy NA, van de Sande MA, Vriens D, Cleven AH, Appelman-Dijkstra NM.

Endocrine. 2016 Dec;54(3):642-647. doi: 10.1007/s12020-016-1092-5. Epub 2016 Oct 5.

20.

En bloc resection for treatment of tumor-induced osteomalacia: a case presentation and a systematic review.

Meng T, Zhou W, Li B, Yin H, Li Z, Zhou L, Kong J, Yan W, Yang X, Liu T, Song D, Xiao J.

World J Surg Oncol. 2015 May 8;13:176. doi: 10.1186/s12957-015-0589-3. Review.

Supplemental Content

Support Center